.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Baxter
Cerilliant
Argus Health
Healthtrust
Merck
UBS
Citi
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,066,976

« Back to Dashboard

Which drugs does patent 8,066,976 protect, and when does it expire?


Patent 8,066,976 protects CLOBEX and is included in one NDA. There have been three Paragraph IV challenges on Clobex.

This patent has thirty-one patent family members in twenty-one countries.

Summary for Patent: 8,066,976

Title:Foaming compositions for hair care
Abstract: The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Inventor(s): Preuilh; Isabelle (Le Cannet, FR), Guise; Anne-Emmanuelle (Rouen, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma S.A. (Cham, CH)
Application Number:12/724,620
Patent Claim Types:
see list of patent claims
Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Galderma LabsCLOBEXclobetasol propionateSHAMPOO;TOPICAL021644-001Feb 5, 2004ABRXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,066,976

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,316,810Foaming composition for washing and treating hair and/or scalp based on an active principle► Subscribe
8,066,975Foaming composition for washing and treating hair and/or scalp based on an active principle► Subscribe
7,700,081Foaming compositions for hair care► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,066,976

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil9911849► Subscribe
Canada2333427► Subscribe
China1306413► Subscribe
China1171579► Subscribe
Germany69928253► Subscribe
Denmark1087747► Subscribe
European Patent Office1087747► Subscribe
European Patent Office1695691► Subscribe
Spain2247805► Subscribe
France2761600► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Mallinckrodt
Chinese Patent Office
Cerilliant
Medtronic
Baxter
McKesson
Julphar
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot